370 related articles for article (PubMed ID: 37629092)
1. Alterations of Oligodendrocyte and Myelin Energy Metabolism in Multiple Sclerosis.
López-Muguruza E; Matute C
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629092
[TBL] [Abstract][Full Text] [Related]
2. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS; Blakemore WF
Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
[TBL] [Abstract][Full Text] [Related]
3. Chronic Demyelination and Axonal Degeneration in Multiple Sclerosis: Pathogenesis and Therapeutic Implications.
Simkins TJ; Duncan GJ; Bourdette D
Curr Neurol Neurosci Rep; 2021 Apr; 21(6):26. PubMed ID: 33835275
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances on Immunosuppressive Drugs and Remyelination Enhancers for the Treatment of Multiple Sclerosis.
Cadenas-Fernández J; Ahumada-Pascual P; Andreu LS; Velasco A
Curr Pharm Des; 2021 Oct; 27(30):3273-3280. PubMed ID: 33504299
[TBL] [Abstract][Full Text] [Related]
5. Multiple Sclerosis and Aging: The Dynamics of Demyelination and Remyelination.
Correale J; Ysrraelit MC
ASN Neuro; 2022; 14():17590914221118502. PubMed ID: 35938615
[TBL] [Abstract][Full Text] [Related]
6. Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.
Dulamea AO
Adv Exp Med Biol; 2017; 958():91-127. PubMed ID: 28093710
[TBL] [Abstract][Full Text] [Related]
7. Insights in pathogenesis of multiple sclerosis: nitric oxide may induce mitochondrial dysfunction of oligodendrocytes.
Lan M; Tang X; Zhang J; Yao Z
Rev Neurosci; 2018 Jan; 29(1):39-53. PubMed ID: 28822986
[TBL] [Abstract][Full Text] [Related]
8. Oligodendrogliopathy in Multiple Sclerosis: Low Glycolytic Metabolic Rate Promotes Oligodendrocyte Survival.
Rone MB; Cui QL; Fang J; Wang LC; Zhang J; Khan D; Bedard M; Almazan G; Ludwin SK; Jones R; Kennedy TE; Antel JP
J Neurosci; 2016 Apr; 36(17):4698-707. PubMed ID: 27122029
[TBL] [Abstract][Full Text] [Related]
9. Oligodendrocytes, BK channels and the preservation of myelin.
Rupnik M; Baker D; Selwood DL
F1000Res; 2021; 10():781. PubMed ID: 34909188
[TBL] [Abstract][Full Text] [Related]
10. Dietary influence on central nervous system myelin production, injury, and regeneration.
Langley MR; Triplet EM; Scarisbrick IA
Biochim Biophys Acta Mol Basis Dis; 2020 Jul; 1866(7):165779. PubMed ID: 32224154
[TBL] [Abstract][Full Text] [Related]
11. Pericytes in Multiple Sclerosis.
Rivera FJ; Hinrichsen B; Silva ME
Adv Exp Med Biol; 2019; 1147():167-187. PubMed ID: 31147878
[TBL] [Abstract][Full Text] [Related]
12. Multiple Sclerosis: Basic and Clinical.
Buzzard K; Chan WH; Kilpatrick T; Murray S
Adv Neurobiol; 2017; 15():211-252. PubMed ID: 28674983
[TBL] [Abstract][Full Text] [Related]
13. Remyelination in multiple sclerosis: realizing a long-standing challenge.
Aharoni R
Expert Rev Neurother; 2015; 15(12):1369-72. PubMed ID: 26558886
[TBL] [Abstract][Full Text] [Related]
14. Oligodendrocyte-derived transcellular signaling regulates axonal energy metabolism.
Li S; Sheng ZH
Curr Opin Neurobiol; 2023 Jun; 80():102722. PubMed ID: 37028201
[TBL] [Abstract][Full Text] [Related]
15. Remyelination: the true regeneration of the central nervous system.
Crawford AH; Chambers C; Franklin RJ
J Comp Pathol; 2013; 149(2-3):242-54. PubMed ID: 23831056
[TBL] [Abstract][Full Text] [Related]
16. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
Olsen JA; Akirav EM
J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
[TBL] [Abstract][Full Text] [Related]
17. Remyelinating strategies: What can be learned from normal brain development.
Shelestak J; Irfan M; DeSilva TM
Curr Opin Pharmacol; 2022 Dec; 67():102290. PubMed ID: 36195009
[TBL] [Abstract][Full Text] [Related]
18. Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination.
Harrington EP; Zhao C; Fancy SP; Kaing S; Franklin RJ; Rowitch DH
Ann Neurol; 2010 Nov; 68(5):703-16. PubMed ID: 20853437
[TBL] [Abstract][Full Text] [Related]
19. The Molecular Basis for Remyelination Failure in Multiple Sclerosis.
Gruchot J; Weyers V; Göttle P; Förster M; Hartung HP; Küry P; Kremer D
Cells; 2019 Aug; 8(8):. PubMed ID: 31382620
[TBL] [Abstract][Full Text] [Related]
20. Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier?
Tepavčević V; Lubetzki C
Brain; 2022 Dec; 145(12):4178-4192. PubMed ID: 36093726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
